Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z DIENSTBIER

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
The International Journal of Biological Markers|January 1, 1990
Distribution, kinetics and immunoscintigraphy of 131-I labelled intact antifibrinogen-fibrin antibody (AbFbg) and its F(ab')2 fragmentP Svihovcova, J Brousil, F Vitek, et al.
The International Journal of Biological Markers|July 1, 1988
Antiferritin antibodies in immunoscintigraphic detection of human tumor xenograftsH Koprivová, F Novák, P Poucková, et al.
Czechoslovak Medicine|January 1, 1981
Retrospective study in 430 patients with Hodgkin's disease (1965-1974)J Zámecník, V Kubec, T Cerná, et al.
Bratislavske Lekarske Listy|October 1, 1989
[Immunoscintigraphy in experiments and clinical practice: its possibilities, advantages and limitations]P Svihovcová, H Koprivová, F Novák, et al.
Folia Biologica|January 1, 1985
Tumour localization of radiolabelled monoclonal antibody in mice bearing human urinary bladder (T24) carcinoma xenograftsJ Bubeník, J Kieler, P Perlmann, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Monoclonal antibodies against human urinary bladder carcinomas: selectivity and utilization for gamma scintigraphyJ Bubeńik, J Kieler, P Perlmann, et al.
Neoplasma|January 1, 1986
Prognostic factors in Hodgkin's diseaseZ Dienstbier, V Foltýnová, Z Hermanská, et al.
The International Journal of Biological Markers|September 1, 1986
The joint Task Group on clinical utility of labelled antibodies of the Society of Nuclear Medicine Europa (SNME) and the European Nuclear Medicine Society (ENMS)G Buraggi, K E Britton, U Büll, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
The International Journal of Biological Markers|January 1, 1990
Distribution, kinetics and immunoscintigraphy of 131-I labelled intact antifibrinogen-fibrin antibody (AbFbg) and its F(ab')2 fragmentP Svihovcova, J Brousil, F Vitek, et al.
The International Journal of Biological Markers|July 1, 1988
Antiferritin antibodies in immunoscintigraphic detection of human tumor xenograftsH Koprivová, F Novák, P Poucková, et al.
Czechoslovak Medicine|January 1, 1981
Retrospective study in 430 patients with Hodgkin's disease (1965-1974)J Zámecník, V Kubec, T Cerná, et al.
Bratislavske Lekarske Listy|October 1, 1989
[Immunoscintigraphy in experiments and clinical practice: its possibilities, advantages and limitations]P Svihovcová, H Koprivová, F Novák, et al.
Folia Biologica|January 1, 1985
Tumour localization of radiolabelled monoclonal antibody in mice bearing human urinary bladder (T24) carcinoma xenograftsJ Bubeník, J Kieler, P Perlmann, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Monoclonal antibodies against human urinary bladder carcinomas: selectivity and utilization for gamma scintigraphyJ Bubeńik, J Kieler, P Perlmann, et al.
Neoplasma|January 1, 1986
Prognostic factors in Hodgkin's diseaseZ Dienstbier, V Foltýnová, Z Hermanská, et al.
The International Journal of Biological Markers|September 1, 1986
The joint Task Group on clinical utility of labelled antibodies of the Society of Nuclear Medicine Europa (SNME) and the European Nuclear Medicine Society (ENMS)G Buraggi, K E Britton, U Büll, et al.
Pageof 6